GlassScriptPhysician profile
Robert N Sinha
NPI 1699767939
$4,698.01
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,504 · 2020: $222 · 2021: $889 · 2022: $571 · 2023: $297 · 2024: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $512.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viewray Technologies INC | $821.57 | 2019 | |
| Palette Life Sciences, INC. | $759.05 | 2021-2022 | |
| Gt Medical Technologies, INC | $658.45 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $375.44 | 2021-2023 | Varian Ethos Treatment Planning, Varian Treatment |
| Icad, INC | $261.50 | 2021-2022 | |
| Boston Scientific Corporation | $212.78 | 2019-2023 | Spaceoar Vue System - 10ml |
| Adc Therapeutics America, INC. | $144.65 | 2024 | |
| Novartis Pharmaceuticals Corporation | $132.12 | 2019-2020 | |
| Hologic INC | $125.00 | 2019 | |
| Varian Medical Systems, INC. | $116.51 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $107.05 | 2019 | |
| Isoray, INC | $102.77 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $95.43 | 2019-2020 | |
| Lilly USA, LLC | $79.37 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $72.43 | 2019-2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $71.94 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $68.67 | 2019-2020 | |
| Celgene Corporation | $65.54 | 2019-2020 | |
| Qfix | $58.46 | 2021 | |
| Incyte Corporation | $52.40 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $51.34 | 2019 | |
| Rigel Pharmaceuticals, INC. | $50.90 | 2019 | |
| Reflexion Medical, INC. | $44.24 | 2024 | Reflexion Medical Radiotherapy System |
| Seagen INC. | $29.82 | 2020 | |
| Amgen INC. | $29.15 | 2019 | |
| Foundation Medicine, INC. | $28.61 | 2019-2020 | |
| Telix Pharmaceuticals | $27.39 | 2024 | Illuccix |
| Blueprint Medicines Corporation | $24.97 | 2020 | |
| Accuray Incorporated | $18.14 | 2019 | |
| Clovis Oncology, INC. | $12.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Sinha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.